Recently, the rapid spread of 2019 novel coronavirus (SARS-CoV-2) has become a global public health issue. As a result, many attempts have been made in disease therapy and population control, but SARS-CoV-2 surveillance still needs to be improved. Real-time reverse transcription polymerase chain reaction (rRT-PCR) has been regarded as the gold standard for in vitro diagnostic of SARS-CoV-2 in human samples. However, this system also presents many limitations, such as high manpower and equipment resources, to detect the SARS-CoV-2 genome. In this condition, the establishment of effective viral screening systems should be beneficial to the rapid diagnostic capacity of SARS-CoV-2 in potential patients. Learn more: RT-LAMP for SARS-CoV-2